探索胃潰瘍和免疫血反應之間的複雜關係:一個敘事性回顧
Emmanuel Ifeanyi Obeagu1, Getrude Uzoma Obeagu2
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Medicine
|April 14, 2025
概括
最近的研究强调了免疫血液学反应在胃发育和愈合中的关键作用. 了解这些免疫系统相互作用为治疗胃潰瘍提供了新的途径.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 胃潰瘍對全球公共衛生產生重大影響.
- 传统上与H.pylori和胃酸有关,但现在人们认为它们的发病包括复杂的免疫血液学因素.
研究的目的:
- 综合和分析胃潰瘍和免疫血反應之間的複雜關係.
- 阐明免疫系统与的发展,进展和愈合之间的相互作用.
主要方法:
- 本综述巩固了关于胃潰瘍疾病免疫方面的当前知识.
- 对炎症媒介,免疫细胞和宿主对H. pylori的反应进行分析.
主要成果:
- 免疫因素,包括细胞因子和化学因子,是粘膜损伤和修复的组成部分.
- 慢性 H. pylori 感染引发先天性和适应性免疫反应,影响.
- 免疫细胞的参与在多面的胃的景观中是相当大的.
结论:
- 免疫血液学反应在胃病原和临床过程中至关重要.
- 需要对免疫路径进行进一步的研究.
- 整合免疫学为针对免疫调节的新型治疗干预提供了机会,以改善患者的治疗结果.
相关概念视频
Peptic Ulcer Disease I: Introduction
105
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
105
Peptic Ulcer Disease II: Pathophysiology
163
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
163
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
481
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
481
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
317
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
317
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
69
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
69
Peptic Ulcer Disease IV: Management
51
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
51


